Mommox (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mommox, is a corticosteroid presented as a nasal formulation for intranasal use. The medication is formulated for topical application within the nasal passages, where it exerts local anti‑inflammatory activity with minimal systemic absorption. It is employed to treat allergic rhinitis, providing symptom relief in both adult and pediatric patients.

GNH USA supplies Mommox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing, regulatory documentation, and logistics support for bulk orders across global markets.

Mommox (mometasone furoate) is a topical nasal corticosteroid used to manage inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: provides relief of intermittent allergy symptoms during pollen seasons. - Perennial allergic rhinitis: controls year‑round nasal inflammation and associated symptoms.

Mommox may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning. - Headache. - Epistaxis (nosebleeds).

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Adrenal suppression with prolonged use.

When using Mommox, several precautions should be observed to ensure safety and effectiveness. - Use as prescribed: follow the prescriber’s instructions for frequency and duration. - Avoid prolonged continuous use: limit treatment to the recommended period to reduce risk of systemic effects. - Do not use if nasal infection or recent nasal surgery is present. - Caution in children: monitor for growth suppression with long‑term therapy. - Monitor for signs of adrenal insufficiency or systemic corticosteroid effects. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Mommox can interact with other medicines; awareness of potential interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase systemic glucocorticoid exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug levels. - Immunosuppressants (e.g., azathioprine, cyclosporine): heightened risk of infection.

Moderate Interactions (Monitor Closely): - Antihistamines: may mask nasal irritation symptoms. - Decongestant nasal sprays (oxymetazoline): combined use can increase local irritation. - Other intranasal steroids: additive anti‑inflammatory effect may increase risk of local side effects.